FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

Viscosity-dependent behaviors such as drips, stringiness, and air entrapment can destabilize fill accuracy and visual inspection, necessitating tailored methodologies and tighter process controls.

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

Aseptic PFS production integrates validated mixing, 0.2 μm sterile filtration, Annex 1/USP-aligned controls, and CCI verification to support sterility assurance throughout shelf life.

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

HUNT VALLEY, Md.--(BUSINESS WIRE)--Pharmaceutics International, Inc. (Pii), a leading contract development and manufacturing organization (CDMO), has announced a significant expansion of its prefilled ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...

A pre-filled syringe with an overmolded near-field communication (NFC) tag allows medical personnel and patients to validate the device's legitimacy, view manufacturing history, see usage ...